Jump to content

Renal medullary carcinoma: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

3 December 2023

16 January 2023

28 December 2022

26 December 2022

14 December 2022

13 December 2022

  • curprev 19:0619:06, 13 December 2022147.206.1.17 talk 11,127 bytes +317 →‎Management: case series of therapy shown to be highly active in patients with metastatic disease<Ryan A, Tawagi K, VanderVeen N, Matrana M, Vasquez R. Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case Series. Clin Genitourin Cancer. 2021 Dec;19(6):e395-e400. doi: 10.1016/j.clgc.2021.08.004. Epub 2021 Aug 27. PMID: 34565708. undo Tags: Reverted extraneous markup

25 November 2021

23 October 2021

13 April 2021

3 January 2021

13 November 2020

18 April 2020

25 June 2019

24 January 2019

10 June 2018

6 June 2017

5 June 2017

1 May 2017

30 December 2016

5 August 2016

5 May 2015

1 May 2015

13 March 2015

6 August 2014

24 July 2014

4 May 2014

29 January 2014

8 January 2014

2 August 2013

20 March 2013

10 December 2012

22 October 2011

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)